RHÖN-KLINIKUM Aktiengesellschaft (
ETR:RHK -
Get Free Report) was up 0.9% during mid-day trading on Tuesday . The stock traded as high as €11.80 ($13.72) and last traded at €11.70 ($13.60). Approximately 474 shares changed hands during trading, a decline of 99% from the average daily volume of 43,281 shares. The stock had previously closed at €11.60 ($13.49).
RHÖN-KLINIKUM Aktiengesellschaft Trading Up 0.9%
The firm has a market cap of $777.63 million, a price-to-earnings ratio of 17.33, a price-to-earnings-growth ratio of 26.77 and a beta of -0.13. The company's 50-day moving average is €11.78 and its 200-day moving average is €12.72.
About RHÖN-KLINIKUM Aktiengesellschaft
(
Get Free Report)
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.
While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.